If this was listed in US the SP would have been double the current price. Still very undervalued but good thing now is company is in much better situation to deal with big pharmaceutical or even can go all alone on phase 3. I believe the big players will try to grab as much shares as possible now to accumulate even if they spike the share price as they very well the worth of it.
I believe eve it will grow much higher as this is only way to accumulate as I won’t be selling if it goes down.
Ann: Opthea Raises A$50 million in Institutional Placement, page-13
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $392.9M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 36.0¢ | 34.5¢ | $257.4K | 732.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 55600 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 58525 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| OPT (ASX) Chart |